175 related articles for article (PubMed ID: 29399131)
1. Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first-line therapy to treat non-HIV patients with severe pneumocystis pneumonia.
Zhang G; Chen M; Zhang S; Zhou H; Ji X; Cai J; Lou T; Cui W; Zhang N
Exp Ther Med; 2018 Feb; 15(2):1594-1601. PubMed ID: 29399131
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection.
Qi H; Dong D; Liu N; Xu Y; Qi M; Gu Q
BMC Infect Dis; 2023 Jun; 23(1):409. PubMed ID: 37328748
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin combined with TMP/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection.
Tian Q; Si J; Jiang F; Xu R; Wei B; Huang B; Li Q; Jiang Z; Zhao T
HIV Med; 2021 Apr; 22(4):307-313. PubMed ID: 33277811
[TBL] [Abstract][Full Text] [Related]
4. A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
Li H; Lu Y; Tian G; Wu Y; Chen T; Zhang J; Hu N; Wang X; Wang Y; Gao L; Yan J; Zhou L; Shi Q
BMC Infect Dis; 2024 Jan; 24(1):152. PubMed ID: 38297200
[TBL] [Abstract][Full Text] [Related]
5. No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study.
Huang Y; He X; Chen H; Harypursat V; Lu Y; Yuan J; Nie J; Liu M; Yu J; Zhang Y; Jiang Z; Qin Y; Xu L; Zhou G; Zhang D; Chen X; Zheng B; Chen Y
Infect Dis Ther; 2022 Feb; 11(1):543-557. PubMed ID: 35050490
[TBL] [Abstract][Full Text] [Related]
6. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of caspofungin, a 1,3-β-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats.
Sun P; Tong Z
Med Mycol; 2014 Nov; 52(8):798-803. PubMed ID: 25288652
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia.
Guo J; Chen Z; Kong C; Yu B; Wang T; Zhang Y; Liu Y; Zhou J; Qiu T
J Chemother; 2023 May; 35(3):181-187. PubMed ID: 35815561
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review.
Li H; Huang H; He H
BMC Pulm Med; 2016 Nov; 16(1):144. PubMed ID: 27835947
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of caspofungin combined with clindamycin for Pneumocystis jirovecii pneumonia in a systemic lupus erythematosus patient: A case report and literature review.
Yang DH; Xu Y; Hong L; Song ZY; Ge WH
Respir Med Case Rep; 2019; 26():108-111. PubMed ID: 30581728
[TBL] [Abstract][Full Text] [Related]
11. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of pneumocystis Carinii pneumonia with caspofungin in elderly patients: a case report and literature review].
Zhang JC; Dai JY; Fan J; Wu XP
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):463-5. PubMed ID: 17045046
[TBL] [Abstract][Full Text] [Related]
13. The influence of PCP prophylaxis on bacteriuria incidence and resistance development to trimethoprim/sulfamethoxazole in HIV-infected patients.
van Dooyeweert DA; Schneider MM; Borleffs JC; Hoepelman AI
Neth J Med; 1996 Dec; 49(6):225-7. PubMed ID: 8990860
[TBL] [Abstract][Full Text] [Related]
14. Lack of response in severe pneumocystis pneumonia to combined caspofungin and clindamycin treatment: a case report.
Yao Z; Hua Z; Jun X; Chan W; Xiao-jun M
Chin Med Sci J; 2011 Dec; 26(4):246-8. PubMed ID: 22218054
[TBL] [Abstract][Full Text] [Related]
15. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
[TBL] [Abstract][Full Text] [Related]
17. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
[TBL] [Abstract][Full Text] [Related]
18. A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.
Kosaka M; Ushiki A; Ikuyama Y; Hirai K; Matsuo A; Hachiya T; Hanaoka M
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893787
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with trimethoprim-sulfamethoxazole and caspofungin in a case of severe pneumocystis pneumonia.
Koshy R; Chen T
IDCases; 2019; 15():e00496. PubMed ID: 30828545
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
Evans RA; Clifford TM; Tang S; Au T; Fugit AM
Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]